CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02411461
NCT02411461N/ACompleted
CompareCT.gov

Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism

Vanderbilt University Medical Center·observational·Posted Apr 8, 2015·Updated Nov 13, 2019

In Brief

An observational study for Pseudohypoparathyroidism and Albright Hereditary Osteodystrophy. Completed, enrolled 39 participants across 1 site.

Detailed Summary

Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and learning difficulties. This study will investigate eating behaviors and perform cognitive testing on children with PHP1a. The investigators will compare their results to those of healthy siblings and other obese children.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPseudohypoparathyroidism, Albright Hereditary Osteodystrophy
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 8, 2015
Enrollment StartDec 1, 2014
Primary CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 11.2 years ago